2,2',2''-trichlorotriethylamine has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 4 studies
2,2',2''-trichlorotriethylamine: RN given refers to parent cpd; structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goodman, LS | 1 |
| Wintrobe, MM | 1 |
| Dameshek, W | 1 |
| Goodman, MJ | 1 |
| Gilman, A | 1 |
| McLennan, MT | 1 |
| Klener, P | 1 |
| Donner, L | 1 |
| Ryabchenko, NI | 1 |
| Jurásková, V | 1 |
| Ivannik, BP | 1 |
| Konov, AV | 1 |
| Drásil, V | 1 |
1 review available for 2,2',2''-trichlorotriethylamine and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Trichlorotriethylamine hydrochloride.
Topics: Adenocarcinoma; Animals; Carcinogens; Carcinoma 256, Walker; Chromosome Aberrations; Drug Evaluation | 1975 |
3 other studies available for 2,2',2''-trichlorotriethylamine and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
Topics: History, 20th Century; Hodgkin Disease; Humans; Leukemia; Lymphoma, Non-Hodgkin; Mechlorethamine; Ne | 1984 |
Trichlortriethylamine (TS-160 Spofa) in combination chemotherapy of malignant lymphomas.
Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymp | 1975 |
The effects of radiation and alkylating agents on chromatin degradation in normal and tumour lymphoid cells.
Topics: Alkylating Agents; Animals; Calcium; Chromatin; Endonucleases; Kinetics; Lymphocytes; Lymphoma, Non- | 1991 |